Novanta Inc.
NOVT | NASDAQ
$144.17
+$9.86 (+7.34%)
At close: Sep 22, 2026, 4:00 PM ET
$143.50
-$0.67 (-0.46%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Company Profile
Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Matthijs Glastra | Chief Executive Officer & Chairman of the Board |
| Charles G. Ravetto | Co-Chief Operating Officer of Automation Enabling Technologies |
| John Lesica | Co-Chief Operating Officer of Medical Solutions |
| Robert J. Buckley | Chief Financial Officer |
| Sarah Betadam | Chief Information Officer & Chief Information Security Officer |
| Alexander Manganiello | General Counsel & Corporate Secretary |
| Heinrich Dreyer | Group President of Medical Solutions |
| John Joseph Burke | Chief Accounting Officer & Corporate Controller |
| Liam Weston | Chief Human Resources Officer |
| Nissia Sabri | Senior Vice President of Corporate Development |
| Ray Nash | Corporate Finance Leader & IR |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Jul 30, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 27, 2026 | 8-K | Current Report |
| Jul 07, 2026 | 4 | Filing |
| Jun 29, 2026 | S-3ASR | Automatic shelf registration statement of securiti... |
| Jun 09, 2026 | 8-K | Current Report |
| Jun 09, 2026 | 8-K | Current Report |
| Jun 04, 2026 | 4 | Filing |
Novanta Inc.
| Country | United States |
| IPO Date | Mar 23, 1999 |
| Industry | Hardware, Equipment & Parts |
| Sector | Technology |
| Employees | 3,000 |
| CEO | Matthijs Glastra |
Contact Details
125 Middlesex Turnpike Bedford,
Massachusetts 01730 United States
Stock Details
| Ticker Symbol | NOVT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001076930 |
| CUSIP Number | 67000B104 |
| ISIN Number | CA67000B1040 |
| SIC Code | 3690 |
Recent News
- 8 days ago / etftrends.comHow to Build a Humanoid Body
- 27 days ago / businesswire.comNovanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026
- 1 month ago / zacks.comRecent Price Trend in Novanta (NOVT) is Your Friend, Here's Why
- 1 month ago / zacks.comAre You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice
- 2 months ago / defenseworld.netNovanta Q2 Earnings Call Highlights
- 2 months ago / zacks.comNovanta (NOVT) Tops Q2 Earnings and Revenue Estimates
- 2 months ago / businesswire.comNovanta Announces Financial Results for the Second Quarter 2026
- 2 months ago / zacks.comWill Novanta (NOVT) Beat Estimates Again in Its Next Earnings Report?
- 2 months ago / zacks.comNovanta (NOVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- 2 months ago / businesswire.comNovanta Completes Acquisition of Riverpoint Medical
Add to Watchlist
Select watchlists to add or remove NOVT